On 17–18 February 2026, the InFlaMe consortium gathered in Pavia, Italy, for its 1st Annual Meeting at Collegio Ghislieri.
The event brought together project partners to review progress across work packages, discuss scientific results, and address key challenges and risks related to the project.
The first day opened with a welcome address by the Coordinator, Prof. Fausto Baldanti (IRCCS OSM), followed by a session on grant implementation led by the Project Officer from the European Health and Digital Executive Agency (HaDEA).[] Presentations from WP1 to WP5 covered topics including project management and coordination, virological, immunological and human genetic risk factors of severe infection, B cell responses and human monoclonal antibody selection, T-cell mediated responses against flaviviruses, and virus–host interactions and drug development.
The second day focused on forward-looking discussion and risk assessment. A roundtable brainstorming session, led by IRCCS OSM, addressed critical aspects and potential risks for the project, held in two parts to allow in-depth debate.
